Characterisation of the osteoclastogenic potential of human osteoblastic and fibroblastic conditioned media

Journal of Cellular Biochemistry

Volumn 109, Issue 1, 2010, Pages 205-216

  Costa Rodrigues, João ^a   Teixeira, Cristina A ^a,b   Sampaio, Paula ^c   Fernandes, Maria H ^a  

^a Portugal   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Conditioned media; Fibroblast; Osteoblast; Osteoclastogenesis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CD14 ANTIGEN; COLONY STIMULATING FACTOR 1; DEXAMETHASONE; MYC PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN; VITRONECTIN;

ADULT; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL INTERACTION; CELL ISOLATION; CONTROL GROUP; CONTROLLED STUDY; CULTURE MEDIUM; FIBROBLAST; HUMAN; HUMAN CELL; MULTINUCLEAR CELL; ONCOGENE SRC; OSTEOBLAST; OSTEOCLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CONTENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST;

ACID PHOSPHATASE; ADULT; ANTIGENS, CD14; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MACROPHAGE COLONY-STIMULATING FACTOR; OSTEOBLASTS; OSTEOCLASTS; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 73849135767     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22398     Document Type: Article

References (39)

1. Bekker PJ, Gay CV. 1990. Biochemical characterization of an electrogenic vacuolar proton pump in purified chicken osteoclast plasma membrane vesicles. J Bone Miner Res 5:569-579.
2. Boyce BF, Xing L. 2008. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139-146.
3. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
4. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Chambers TJ. 2000. Regulation of the differentiation and function of osteoclasts. J Pathol 192:4-13.
6. Chen TL, Feldman D. 1979. Glucocorticoid receptors and actions in subpopulations of cultured rat bone cells. Mechanism of dexamethasone potentiation of parathyroid hormone-stimulated cyclic AMP production. J Clin Invest 63:750-758.
7. Cochran DL, Rouse CA. 1993. The effect of conditioned medium from connective tissue fibroblasts and epithelium on calcium release from mouse calvarial organ culture. Arch Oral Biol 38:61-65.
8. Datta HK, Ng WF, Walker JA, Tuck SP, Varanasi SS. 2008. The cell biology of bone metabolism. J Clin Pathol 61:577-587.
9. Fujita K, Janz S. 2007. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol Cancer 6:71.
10. Galicka A, Wolczynski S, Gindzienski A. 2002. Comparative studies of osteoblast and fibroblast type I collagen in a patient with osteogenesis imperfecta type IV. J Pathol 196:235-237.
11. Hashizume M, Hayakawa N, Mihara M. 2008. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology (Oxford) 47:1635-1640.
12. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S. 1999. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389.
13. Holt I, Davie MW, Marshall MJ. 1996. Osteoclasts are not the major source of interleukin-6 in mouse parietal bones. Bone 18:221-226.
14. Jimi E, Nakamura I, Ikebe T, Akiyama S, Takahashi N, Suda T. 1998. Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1. J Biol Chem 273:8799-8805.
15. Kaku M, Motokawa M, Tohma Y, Tsuka N, Koseki H, Sunagawa H, Arturo Marquez Hernandes R, Ohtani J, Fujita T, Kawata T, Tanne K. 2008. VEGF and M-CSF levels in periodontal tissue during tooth movement. Biomed Res 29:181-187.
16. Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, Kim JH, Kobayashi T, Odgren PR, Nakano H, Yeh WC, Lee SK, Lorenzo JA, Choi Y. 2005. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202:589-595.
17. Kim NS, Kim HJ, Koo BK, Kwon MC, Kim YW, Cho Y, Yokota Y, Penninger JM, Kong YY. 2006. Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2. Mol Cell Biol 26:1002-1013.
18. Koreny T, Tunyogi-Csapo M, Gal I, Vermes C, Jacobs JJ, Glant TT. 2006. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum 54:3221-3232.
19. Lagasse E, Weissman IL. 1997. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89:1021-1031.
20. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481-1488.
21. Legendre F, Dudhia J, Pujol JP, Bogdanowicz P. 2003. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression. J Biol Chem 278:2903-2912.
22. Marie PJ, Debiais F, Hay E. 2002. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. Histol Histopathol 17:877-885.
23. Motokawa M, Kaku M, Tohma Y, Kawata T, Fujita T, Kohno S, Tsutsui K, Ohtani J, Tenjo K, Shigekawa M, Kamada H, Tanne K. 2005. Effects of cyclic tensile forces on the expression of vascular endothelial growth factor (VEGF) and macrophage-colony-stimulating factor (M-CSF) in murine osteoblastic MC3T3-E1 cells. J Dent Res 84:422-427.
24. Nicholson GC, Malakellis M, Collier FM, Cameron PU, Holloway WR, Gough TJ, Gregorio-King C, Kirkland MA, Myers DE. 2000. Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin Sci (Lond) 99:133-140.
25. Nishiguchi M, Yuasa K, Saito K, Fukumoto E, Yamada A, Hasegawa T, Yoshizaki K, Kamasaki Y, Nonaka K, Fujiwara T, Fukumoto S. 2007. Amelogenin is a negative regulator of osteoclastogenesis via downregulation of RANKL, M-CSF and fibronectin expression in osteoblasts. Arch Oral Biol 52:237-243.
26. Okada H, Danoff TM, Fischer A, Lopez-Guisa JM, Strutz F, Neilson EG. 1998. Identification of a novel cis-acting element for fibroblast-specific transcription of the FSP1 gene. Am J Physiol 275:F306-F314.
27. Pereira ML, Carvalho JC, Peres F, Fernandes MH. 2009. Effect of nicotine in matrix mineralization by human bone marrow and Saos-2 cells cultured on the surface of plasma-sprayed titanium implants. J Biomed Mater Res A 88:84-93.
28. Pixley FJ, Stanley ER. 2004. CSF-1 regulation of the wandering macrophage: Complexity in action. Trends Cell Biol 14:628-638.
29. Ragab AA, Nalepka JL, Bi Y, Greenfield EM. 2002. Cytokines synergistically induce osteoclast differentiation: Support by immortalized or normal calvarial cells. Am J Physiol Cell Physiol 283:C679-C687.
30. Rucci N, Rufo A, Alamanou M, Teti A. 2007. Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio. J Cell Biochem 100:464-473.
31. Sato K, Takayanagi H. 2006. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol 18:419-426.
32. Suda TUN, Takahashi N. 1996. Cells of bone: Osteoclast generation. In: Bilezikian JP RL, Rodan GA, editors. Principles of bone biology. San Diego: Academic Press. pp 87-102.
33. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T. 1988. Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600-2602.
34. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, Martin TJ, Hirota H, Taga T, Kishimoto T, Suda T. 1995. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 182:1461-1468.
35. Udagawa N, Kotake S, Kamatani N, Takahashi N, Suda T. 2002. The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res 4:281-289.
36. Vaananen HK, Laitala-Leinonen T. 2008. Osteoclast lineage and function. Arch Biochem Biophys 473:132-138.
37. Walsh NC, Crotti TN, Goldring SR, Gravallese EM. 2005. Rheumatic diseases: The effects of inflammation on bone. Immunol Rev 208:228-251.
38. Weiss MJ, Ray K, Fallon MD, Whyte MP, Fedde KN, Lafferty MA, Mulivor RA, Harris H. 1989. Analysis of liver/bone/kidney alkaline phosphatase mRNA, DNA, and enzymatic activity in cultured skin fibroblasts from 14 unrelated patients with severe hypophosphatasia. Am J Hum Genet 44:686-694.
39. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442-444.